Decreased serum undercarboxylated osteocalcin is associated with cognitive impairment in male patients with type 2 diabetes
Basic and clinical researches have suggested that type 2 diabetes (T2DM) is associated with cognitive impairment, and diabetes mellitus increases the risk of cognitive impairment and dementia. Recently, some reports found that undercarboxylated osteocalcin (ucOC) could affect brain functions, and decreased in patients with T2DM. We aimed to investigate the association of serum ucOC with cognitive impairment in T2DM patients.
Source: Journal of Diabetes and Its Complications - Category: Endocrinology Authors: Hui Fang, Xiao-yu Xu, Rui-zhe Xu, Yan-feng Zhen, Gang Xu, Yu-kai Li Source Type: research
More News: Brain | Dementia | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Neurology